Delivery Order SPE2DB22D3016-SPE2DB25FABM3

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,263.55 firm fixed-price delivery order is for the supply of SUNOSI 150 MG TABLET 30S, with a completion date of February 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of medical products, including Sunosi 75 mg tablets. The $2,181.88 firm fixed-price delivery order has a completion date of January 31, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,600.17 for the supply of Sunosi 150 mg tablets. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of Amerisourcebergen. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which enables the agency to efficiently procure a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,300.53 firm fixed-price delivery order is for the supply of 4564660570 SUNOSI 150 MG TABLET 30S to support the Department of Defense's (DoD) medical programs. AmerisourceBergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SUNOSI 75 MG TABLET 30S. The award, valued at $1,299.54, is a firm fixed-price contract with a completion date of July 26, 2024. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to provide a wide range of pharmaceutical products and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,369.99 firm fixed price contract is for the supply of Sunosi 75 mg tablets to support military healthcare programs. The contract has a period of performance through January 31, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,665.97, is for the delivery of Sunosi 150 mg tablets and has an ultimate completion date of November 7, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. No set-aside was used for this award. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds an Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $2,137.38, is for the delivery of 4564312551 - SUNOSI 150 MG TABLET 30S. This is a firm-fixed price delivery order contract with a completion date of April 18, 2024. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,856.85, is for the delivery of 4567140528 – SUNOSI 75 MG TABLET 30S medical supplies. The contract is a Delivery Order with a Firm Fixed Price pricing type. It has an ultimate completion date of February 4, 2025. This award is not designated as a set-aside contract....
This federal contract award, valued at $13,005.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FABM3
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,205.52 firm-fixed-price delivery order contract is for the supply of SUNOSI 75 MG Tablets. The contract has an ultimate completion date of October 25, 2024.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 1/23/25, 9:27 AM